Ngā hua rapu - ROMMEL, BIRGIT

  • E whakaatu ana i te 1 - 4 hua o te 4
Whakamahine hua
  1. 1
    Factors targeting MED12 to drive tumorigenesis?

    Factors targeting MED12 to drive tumorigenesis? mā Bullerdiek, Jörn, Rommel, Birgit

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    ABO blood groups and the risk of SARS-CoV-2 infection

    ABO blood groups and the risk of SARS-CoV-2 infection mā Bullerdiek, Jörn, Reisinger, Emil, Rommel, Birgit, Dotzauer, Andreas

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Reasons to Reconsider Risk Associated With Power Morcellation of Uterine Fibroids

    Reasons to Reconsider Risk Associated With Power Morcellation of Uterine Fibroids mā HOLZMANN, CARSTEN, KUEPKER, WOLFGANG, ROMMEL, BIRGIT, HELMKE, BURKHARD, BULLERDIEK, JOERN

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Activation of the two microRNA clusters C19MC and miR-371-3 does not play prominent role in thyroid cancer

    Activation of the two microRNA clusters C19MC and miR-371-3 does not play prominent role in thyroid cancer mā Rippe, Volkhard, Flor, Inga, Debler, Johannes Wolfram, Drieschner, Norbert, Rommel, Birgit, Krause, Daniel, Junker, Klaus, Bullerdiek, Jörn

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: